Financials WuXi XDC Cayman Inc.

Equities

2268

KYG9808A1058

Pharmaceuticals

End-of-day quote Hong Kong S.E. 06:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
19.06 USD +0.63% Intraday chart for WuXi XDC Cayman Inc. -17.31% -40.44%

Valuation

Fiscal Period: December 2023 2024 2025
Capitalization 1 20,621 20,621 -
Enterprise Value (EV) 1 34,275 17,254 17,421
P/E ratio 112 x 36.1 x 22.8 x
Yield - - -
Capitalization / Revenue 16.1 x 6.53 x 4.47 x
EV / Revenue 16.1 x 5.46 x 3.78 x
EV / EBITDA 92 x 21.7 x 13.9 x
EV / FCF -23.3 x -19.8 x -399 x
FCF Yield -4.3% -5.05% -0.25%
Price to Book 4.18 x 3.54 x 3.06 x
Nbr of stocks (in thousands) 1,178,446 1,178,446 -
Reference price 2 17.61 17.61 17.61
Announcement Date 3/25/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - 2,124 3,160 4,614
EBITDA 1 - 372.5 793.3 1,249
EBIT 1 - 343.5 661.1 1,067
Operating Margin - 16.17% 20.92% 23.12%
Earnings before Tax (EBT) 1 - 359.6 704.9 1,125
Net income 1 155.7 283.5 575.5 918.3
Net margin - 13.35% 18.21% 19.9%
EPS 2 0.1800 0.2600 0.4873 0.7726
Free Cash Flow 1 - -735 -870.7 -43.62
FCF margin - -40.71% -27.55% -0.95%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share 2 - - - -
Announcement Date 11/6/23 3/25/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 S2 2024 S1 2024 S2
Net sales 1 875.9 1,392 1,702
EBITDA - - -
EBIT 1 168 337.6 423.4
Operating Margin 19.18% 24.25% 24.88%
Earnings before Tax (EBT) 1 70 - -
Net income 1 56 - -
Net margin 6.39% - -
EPS 2 0.0400 - -
Dividend per Share - - -
Announcement Date - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt 1 - - - -
Net Cash position 1 - 3,519 3,367 3,201
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 - -735 -871 -43.6
ROE (net income / shareholders' equity) - 8.35% 10.2% 14.2%
ROA (Net income/ Total Assets) - 5.57% 9.45% 12%
Assets 1 - 4,456 6,089 7,671
Book Value Per Share 2 - 4.210 4.980 5.750
Cash Flow per Share 2 - 0.3600 0.6000 0.7500
Capex 1 - 695 1,546 918
Capex / Sales - 38.47% 48.92% 19.9%
Announcement Date 11/6/23 3/25/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
17.61 CNY
Average target price
28.8 CNY
Spread / Average Target
+63.53%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 2268 Stock
  4. Financials WuXi XDC Cayman Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW